Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

Psaty, BM Weiss, NS Furberg, CD Koepsell, TD Siscovick, DS Rosendaal, FR Smith, NL Heckbert, SR Kaplan, RC Lin, DY Fleming, TR Wagner, EH

Bm. Psaty et al., Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease, J AM MED A, 282(8), 1999, pp. 786-790

41

General & Internal Medicine","Medical Research General Topics

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

00987484 → ACNP

282

8

1999

786 - 790

ISI

0098-7484(19990825)282:8<786:SEPHOA>2.0.ZU;2-N